A5001819044- Rheumatoid Arthritis Research and Therapies
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Vasculitis and related conditions
- Lymphoma Diagnosis and Treatment
- Heparin-Induced Thrombocytopenia and Thrombosis
- Peripheral Neuropathies and Disorders
- Sarcoidosis and Beryllium Toxicity Research
- Tuberculosis Research and Epidemiology
- Infectious Diseases and Tuberculosis
- Hepatitis C virus research
- Eosinophilic Disorders and Syndromes
- Renal Diseases and Glomerulopathies
- Cell Adhesion Molecules Research
- Leprosy Research and Treatment
Kyoto Prefectural University of Medicine
2022-2024
ORCID
2024
Data Management (Italy)
2024
Matsushita Memorial Hospital
2024
Japanese Red Cross Society Kyoto Daini Hospital
2023
To investigate the association between decreased serum IgG levels caused by remission-induction immunosuppressive therapy of antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and development severe infections.We conducted a retrospective cohort study patients with new-onset or relapsing AAV enrolled in J-CANVAS registry, which was established at 24 referral sites Japan. The minimum up to weeks incidence infection 48 after treatment initiation were evaluated. After multiple...
Abstract Filgotinib, a janus kinase 1 (JAK1) inhibitor, is used in the treatment of rheumatoid arthritis (RA). RA‐associated interstitial lung disease (RA‐ILD) severe RA complication with no established effective treatment. We report case patient RA‐ILD successfully treated filgotinib. A 46‐year‐old woman and RA‐ILD, presenting non‐specific pneumonia pattern, was refractory to abatacept prednisolone but responded Both improved significantly, remained remission for over 12 months. Basic...
Rheumatoid pleural effusion (RPE) is a rare complication of rheumatoid arthritis (RA) with no sufficiently established treatment. Sarilumab, monoclonal antibody targeting the interleukin-6 receptors, widely used to treat RA. Here, we present case 68-year-old man refractory RA and RPE, who was successfully treated sarilumab. The patient presented polyarthritis effusion. Based on serum fluid test results, he diagnosed RPE but did not respond prednisolone (PSL) therapy. Notably, resolved after...
ABSTRACT The Epstein-Barr virus (EBV) is associated with various lymphoproliferative disorders (LPDs). Additionally, EBV infection has correlated diverse autoimmune diseases. However, the association between and systemic small vessel vasculitis (SVV) remains controversial. Here, we report a case of SVV pauci-immune glomerulonephritis accompanied by an EBV-positive polymorphic B-cell LPD, not otherwise specified. intricate distinction LPD was difficult, as both diseases demonstrated similar...
From the Department of Rheumatology, Matsushita Memorial Hospital, Osaka, Japan. Atsuhiko Sunaga, ORCID ID: 0009-0007-8346-9216 The authors declare no conflict interest. Correspondence: MD, 5-55 Sotojima-cho, Moriguchi-shi, Osaka 570-8540, E-mail: [email protected]. Author Contributions: data collection and case management: A.S., T.I.; writing—original draft preparation: A.S.; writing—review editing: supervision: T.I.
We conducted a single-center cohort study of rheumatoid arthritis (RA) patients from 2011 to 2020 understand their real world treatment and outcomes, especially changes in physical function quality life (QOL) elderly patients, including those aged ≥ 80 years.For RA attending our outpatient clinic, we annually recorded tender swollen joint counts, laboratory findings, therapeutic drugs, scores the Japanese Health Assessment Questionnaire EuroQoL-5 Dimensions questionnaire. examined outcomes...